UnitedHealth hit with fresh Medicare claims: what it could mean for UNH stock

UnitedHealth is back under the regulatory spotlight, with fresh scrutiny of its Medicare business arriving just as investors are still digesting earlier legal and political blows. The new accusations raise questions about how much legal risk is already reflected in UNH’s valuation and how much more volatility shareholders should brace for. I see a company…

Read More